Characterizing outcomes of ERBB2-amplified biliary tract cancer.

被引：0
|
作者：
Fox, Daniel Aaron
Haro-Silerio, Jaime
Bhamidipati, Deepak
Meric-Bernstam, Funda
Pant, Shubham
Ross, Jeffrey S.
Hu, Zishuo Ian
Koay, Eugene Jon
Ludmir, Ethan B.
Cao, Hop Sanderson Tran
Tzeng, Ching-Wei D.
Chun, Yun Shin
Vauthey, Jean-Nicolas
Newhook, Timothy E.
Metwalli, Zeyad
Habibollahi, Peiman
Cox, Veronica L.
Kang, Hyunseon
Javle, Milind M.
Lee, Sunyoung S.
机构：
[1] Baylor Coll Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA
[5] Fdn Med Inc, Cambridge, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Abdominal Imaging, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-492-3532-2370-7650-2700; 283-237-2581-144; 298-4768-3691-2722; 261-7540; 613-4678-146; 261-492-9019; 6; 3; 2; 291; 176; 1; 38092-22447; 38092-34303; 38092-18909; 38092-30467; 38092-19994; 38092-32474; 38092-25821; 38092-20248; 38092-20245; 38092-20212; 38092-27371; 38092-33627; 38092-30779; 38092-27507; 38114-38096-7094; 38092-24862; 38092-23140; 38092-22449; 38092-18438; 14; 5; 4;
D O I：
10.1200/JCO.2024.42.3_suppl.492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [11] Biological profiles of two ERBB2-amplified human breast cancer xenografts diversely sensitive to Trastuzumab
    de Plater, L.
    Marangoni, E.
    Assayag, F.
    Auger, N.
    Degeorges, A.
    Guyader, C.
    Vincent-Salomon, A.
    de Cremoux, R.
    Decaudin, D.
    Poupon, M. -F.
    EJC SUPPLEMENTS, 2007, 5 (08): : 23 - 23
  • [12] WGS analysis of Erbb2-amplified cervical cancer with two simultaneous histologic types: Transdifferentiation hypothesis
    Ikushima, Hiroaki
    Uchino, Keita
    Yamaguchi, Kiyoshi
    Koda, Seiya Imoto Hirotomo
    Mizukami, Takuro
    Morikawa, Teppei
    Furukawa, Yoichi
    ANNALS OF ONCOLOGY, 2023, 34 : S1445 - S1445
  • [13] Effect of body mass index on outcomes in biliary tract cancer.
    Doherty, Mark
    McNamara, Mairead Geraldine
    Aneja, Priya
    Le, Lisa W.
    Cleary, Sean P.
    Horgan, Anne M.
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [14] Regarding HER2-Amplified Biliary Tract Cancer
    Pant, Shubham
    ONCOLOGIST, 2021, 26 (09): : E1664 - E1664
  • [15] Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer
    Saip, P.
    Eralp, Y.
    Ozkan, M.
    Karaca, H.
    Benekli, M.
    Cetin, B.
    Isikdogan, A.
    Kucukoner, M.
    Basaran, G.
    Sen, F.
    Un, O.
    Onur, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [16] Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs
    Henjes, F.
    Bender, C.
    von der Heyde, S.
    Braun, L.
    Mannsperger, H. A.
    Schmidt, C.
    Wiemann, S.
    Hasmann, M.
    Aulmann, S.
    Beissbarth, T.
    Korf, U.
    ONCOGENESIS, 2012, 1 : e16 - e16
  • [17] Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors
    Kirouac, Daniel C.
    Du, Jin Y.
    Lahdenranta, Johanna
    Overland, Ryan
    Yarar, Defne
    Paragas, Violette
    Pace, Emily
    McDonagh, Charlotte F.
    Nielsen, Ulrik B.
    Onsum, Matthew D.
    SCIENCE SIGNALING, 2013, 6 (288)
  • [18] Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma
    Kim, Jihun
    Fox, Cameron
    Peng, Shouyong
    Pusung, Mark
    Pectasides, Eirini
    Matthee, Eric
    Hong, Yong Sang
    Do, In-Gu
    Jang, Jiryeon
    Thorner, Aaron R.
    Van Hummelen, Paul
    Rustgi, Anil K.
    Wong, Kwok-Kin
    Zhou, Zhongren
    Tang, Ping
    Kim, Kyoung-Mee
    Lee, Jeeyun
    Bass, Adam J.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12): : 5145 - 5158
  • [19] Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs
    F Henjes
    C Bender
    S von der Heyde
    L Braun
    H A Mannsperger
    C Schmidt
    S Wiemann
    M Hasmann
    S Aulmann
    T Beissbarth
    U Korf
    Oncogenesis, 2012, 1 : e16 - e16
  • [20] Patterns of care and treatment outcomes in older patients with biliary tract cancer.
    Horgan, Anne M.
    McNamara, Mairead G.
    Aneja, Priya
    Le, Lisa W.
    McKeever, Elizabeth
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345